The wound had been present for 6 weeks when the patient entered the clinic for DEBRICHEM treatment. The lesion on the right forefoot was severely infected with underlying vasculitis. The wound has only been treated palliative prior to DEBRICHEM application.
Cost-effectiveness of Debrichem in managing hard-to-heal venous leg ulcers in the UK
Objective: To estimate whether the topical debriding agent, Debrichem, could potentially afford the UK’s National Health Service (NHS) a cost-effective intervention for the management of
